Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Kidney cancer

Recurrence in renal cell carcinoma: the work is not done

Recurrences can occur in up to 30% of surgically managed patients with localized renal cell carcinoma. Existing uro-oncological guidelines differ in recommendations of surveillance protocols and identification of patients at risk. A recent study shows that the existence of differing guidelines results in inadequate harms, cancer control and costs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7–30 (2016).

    Article  Google Scholar 

  2. Janzen, N. K., Kim, H. L., Figlin, R. A. & Belldegrun, A. S. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol. Clin. North Am. 30, 843–852 (2003).

    Article  Google Scholar 

  3. Sun, M. et al. Treatment management of small renal masses in the 21st century: a paradigm shift. Ann. Surg. Oncol. 19, 2380–2387 (2012).

    Article  Google Scholar 

  4. Lobo, J., Nelson, M., Nandanan, N. & Krupski, T. Comparison of renal cell carcinoma surveillance guidelines: competing tradeoffs. J. Urol. http://dx.doi.org/10.1016/j.juro.2015.12.094 (2016)

  5. Donat, S. M. et al. Follow-up for clinically localized renal neoplasms: AUA guideline. J. Urol. 190, 407–416 (2013).

    Article  Google Scholar 

  6. Kassouf, W. et al. Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma. Can. Urol. Assoc. J. 3, 73–76 (2009).

    Article  Google Scholar 

  7. Ljungberg, B. et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur. Urol. 67, 913–924 (2015).

    Article  Google Scholar 

  8. Motzer, R. J. et al. Kidney cancer, version 3.2015. J. Natl Compr. Canc. Netw. 13, 151–159 (2015).

    Article  Google Scholar 

  9. Holden, W. L., Juhaeri, J. & Dai, W. Benefit-risk analysis: a proposal using quantitative methods. Pharmacoepidemiol. Drug Saf. 12, 611–616 (2003).

    Article  Google Scholar 

  10. Schutz, F. A. et al. Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study. Lancet Oncol. 14, 81–87 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maxine Sun.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, M., Choueiri, T. Recurrence in renal cell carcinoma: the work is not done. Nat Rev Urol 13, 246–247 (2016). https://doi.org/10.1038/nrurol.2016.57

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2016.57

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing